Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines

FEBS Letters

Volumn 465, Issue 2-3, 2000, Pages 124-128

  Mori, Toshiyuki ^a   Okamoto, Hiroshi ^a   Takahashi, Naoko ^a   Ueda, Ryuzo ^a   Okamoto, Takashi ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

DNA damaging agent; p53; p53 binding protein 2

Indexed keywords

BINDING PROTEIN; CISPLATIN; COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CELL LINE; CONTROLLED STUDY; DNA DAMAGE; DRUG SENSITIVITY; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LUNG CANCER; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION; X IRRADIATION;

CARRIER PROTEINS; CISPLATIN; DNA DAMAGE; DNA, COMPLEMENTARY; LUNG NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS; X-RAYS;

EID: 0033970863     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)01726-3     Document Type: Article

References (23)

1. Iwabuchi K., Bartel P.L., Li B., Marraccino R., Fields S. Proc. Natl. Acad. Sci. USA. 91:1994;6098-6102.
2. Thukral S.K., Blain G.C., Chang K.K., Fields S. Mol. Cell Biol. 14:1994;8315-8321.
3. Gorina S., Pavletich N.P. Science. 274:1996;1001-1005.
4. Naumovski L., Cleary M.L. Mol. Cell Biol. 16:1996;3884-3892.
5. Iwabuchi K., Li B., Massa H.F., Trask B.J., Date T., Fields S. J. Biol. Chem. 273:1998;26061-26068.
6. Sparks A.B., Rider J.E., Hoffman N.G., Fowlkes D.M., Quilliam L.A., Kay B.K. Proc. Natl. Acad. Sci. USA. 93:1996;1540-1544.
7. Helps N.R., Barker H.M., Elledge S.J., Cohen P.T. FEBS Lett. 377:1995;295-300.
8. Yang J.P., Kawabe T., Okamoto T. Oncogene. 18:1999;5177-5186.
9. Levine A.J. Cell. 88:1997;323-331.
10. Ko L.J., Prives C. Genes Dev. 10:1996;1054-1072.
11. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. Science. 253:1991;49-53.
12. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning, 2nd edn., pp. 9.16-9.19, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
13. Motoji N., Hayama E., Shigematsu A. Eur. J. Drug Metab. Pharmacokinet. 20:1995;89-105.
14. Hong W.S., Saijo N., Sasaki Y., Minato K., Nakano H., Nakagawa K., Fujiwara Y., Nomura K., Twentyman P.R. Int. J. Cancer. 41:1988;462-467.
15. Green R.A., Humphrey R.W., Close H., Patno M.E. Am. J. Med. 46:1969;516-525.
16. Carmichael J., Degraff W.G., Gamson J., Russo D., Gazdar A.F., Levitt M.L., Minna J.D., Mitchell J.B. Eur. J. Cancer Clin. Oncol. 3:1989;527-534.
17. Yang J.P., Ono T., Sonta S., Kawabe T., Okamoto T. Cytogenet. Cell Genet. 78:1997;61-62.
18. Volm M., Mattern J. Crit. Rev. Oncog. 7:1996;227-244.
19. Jia L.Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T. Mol. Carcinog. 19:1997;243-253.
20. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., Minty A., Chalon P., Lelias JM., Dumont X., Ferrara P., Mckeon F., Caput D. Cell. 90:1997;809-819.
21. Osada M., Ohba M., Kawahara C., Ishioka C., Kanamaru R., Katoh I., Ikawa Y., Ikawa S. Nat. Med. 4:1998;839-843.
22. Senoo M., Seki N., Ohira M., Sugano S., Watanabe M., Inuzuka S., Okamoto T., Kato H. Biochem. Biophys. Res. Commun. 248:1998;603-607.
23. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M.D., Dotsch V., Andrews N.C., Caput D., McKeon F. Mol. Cell. 2:1998;305-316.